Novo Nordisk A/S
NVO
$61.85
$3.656.27%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.06% | 15.82% | 20.61% | 27.14% | 37.16% |
| Total Depreciation and Amortization | 40.67% | 6.10% | -9.01% | -5.28% | 8.89% |
| Total Amortization of Deferred Charges | 18.52% | 18.52% | 18.52% | 14.80% | 14.80% |
| Total Other Non-Cash Items | 47.09% | 302.89% | -17.55% | 43.66% | -58.28% |
| Change in Net Operating Assets | -2,148.18% | -46.21% | 7.28% | -706.06% | 104.61% |
| Cash from Operations | 6.93% | 39.31% | 11.11% | 11.55% | 31.45% |
| Capital Expenditure | -65.74% | -74.13% | -82.46% | -91.96% | -86.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -11,983.50% | -- | -- | 90.08% | 90.08% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 144.40% | -51.64% | 101.63% | 22.54% | -12.73% |
| Cash from Investing | -196.96% | -314.30% | -190.78% | -23.89% | -32.43% |
| Total Debt Issued | 240.38% | -- | -- | 36,354.74% | 52,996.92% |
| Total Debt Repaid | -1,200.60% | -1,282.08% | -331.83% | -368.34% | -335.35% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 56.91% | 32.03% | 32.56% | 18.96% | -0.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.84% | -18.84% | -40.21% | -40.21% | -55.16% |
| Other Financing Activities | -- | 1,008.73% | -- | -- | -- |
| Cash from Financing | 35.92% | 157.07% | 112.20% | 36.00% | 26.10% |
| Foreign Exchange rate Adjustments | -294.17% | 62.40% | 485.36% | 32.55% | 141.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.65% | 482.86% | -12.51% | 841.37% | 4,664.26% |